Areas of Ongoing Research Scientists continue to investigate several aspects of both compounds: Long-term efficacy: How do effects persist beyond initial trial periods
In a landmark trial, adults using semaglutide for weight management lost close to 15 percent of their body weight on average with consistent use and lifestyle support
Available from: Carris NW, Wallace S, DuCoin CG, Mhaskar R, Stern M, Bunnell B
Blumer I, Pettus JH, Santos CT
Given the scale of potential exposure, we will continue to weigh the implications of GLP-1 drugs cautiously
Highlights of access and reimbursement policies of approved therapies, barriers to accessibility of expensive off-label therapies, and patient assistance programs